@OwkinScience profile picture
Owkin @OwkinScience

Owkin uses artificial intelligence to find the right treatment for every patient.

Joined September 2016
  • Posts 2,808
  • Following 1,692
  • Followers 4,425
1,266 Photos and videos
Get under the hood of our AI scientist, K Pro. Built to draw insights from raw, multimodal biomedical data, directly within the systems pharma teams already use. K Pro combines a simple interface with a powerful architecture. See how it's built: owkin.com/k-os/k-pro-archite…
2:36
1
269
Following @AnthropicAI announcement at The Briefing: AI for Science 2026 event today, including Claude Science, Anthropic’s AI workbench for scientists, we are excited to share that our agentic platform, K Pro, currently reasons through frontier models, including Claude.
1
1
205
We believe that K Pro and leading frontier models like Claude can be used together to solve biology to accelerate cures for many yet unsolved diseases. Read the blog: owkin.com/blogs-case-studies… Learn more about K Pro: owkin.com/k-os/k-pro
1
1
121
Whole-slide images in oncology: incredible data, painful workflow. Download heavy files, switch to separate viewers, switch back to run your models. K Pro's new interactive viewer lets you explore slides in fullscreen, right inside your analysis session. owkin.com/k-os/k-pro
0:39
3
264
Owkin reposted
Aubrey de Grey
 @aubreydegrey
Jun 27
New podcast: youtu.be/1JFFFWsepH8

Owkin x Superhuman Podcast | Aubrey de Grey

Godfather of longevity research Aubrey de Grey talks to Thomas Cloz...

youtube.com
1
10
52
6,654
One axis (COX2–PGE2/PGD2) suppresses T cells, NK cells, DCs, and myeloid cells simultaneously through a single second messenger. New Owkin blog: the mechanism behind OKN4395, our triple EP2/EP4/DP1 antagonist. owkin.com/blogs-case-studies…
2
226
⏳ 10 days to apply for Rewiring Biology. Spots going fast. San Francisco. July 11–12. The clock's running: luma.com/4s2r63rg
238
Want to better understand Owkin’s recently announced 5-year collaboration with Sanofi? Our Head of Product Jonas Béal beal talks to Brian K. Buntz from R&D world about the agentic functionality, interoperability and validation steps we’ll be working on. rdworldonline.com/qa-owkins-…
1
2
222
Here’s the hard truth about longevity: we don’t know what works. Our CEO @TClozel on some of the big ideas in longevity and how we’ll need artificial superintelligence to fully get to grips with the science of aging. 📰 Read the full article here: fastcompany.com/91559811/her…
1
156
Owkin CEO @TClozel sits down with longevity expert Matthew Scholz, CEO of Oisín, in our joint podcast w/ Super Human to discuss gene editing, Bowhead whale physiology, and why having billionaires focussed on the field of aging will be good for everybody. youtu.be/3c5W0-BJSpU
0:25
5
10
1,446
Drug discovery teams could pursue an unlimited number of hypotheses, but only investigate a handful each year. New blog on how Owkin's aging research program approaches that choice, and what it means for K Pro: owkin.com/blogs-case-studies…
1
1
177
The most expensive decision in biotech is the one nobody makes. We sat down with Biotech leaders at one of our recent thought leadership dinners in Boston. The conversation was candid - what are we risking every day we fail to adopt AI? Find out here: owkin.com/blogs-case-studies…
100
🚀 Applications open: Rewiring Biology, Owkin's hackathon in San Francisco on July 11–12. 50 spots. Frontier builders. AI tools for biomedical research. Apply: luma.com/4s2r63rg
1
1
3,151
Thank you @jpmorgan for hosting us at the European Healthcare Symposium in London during Tech Week. It was a fantastic opportunity for our CFO, Graeme Bell, and leadership team to engage with investors and share more about our vision at the intersection of AI and healthcare.
101
Last week, our executive committee visited our wet lab in Paris to see first-hand how Owkin is continuously validating our AI results in real world science. It was inspiring. Learn more about our approach → owkin.com/blogs-case-studies…
1
151
Our co-CEO Pascal Weinberger had the opportunity to speak with @BNPParibas to a select audience of business leaders on how AI is creating revenue across different sectors of the economy, how it is enabling efficiencies and how AI can improve sovereignty within countries.
1
1
129
Introducing K Pro’s KOL-certified skills. We’re working with leading scientists from our global KOL network, to distill their insights into skills usable in K Pro - to give you an expert angle on your scientific question. Find out more about K Pro → owkin.com/k-os/k-pro
0:25
199
🇫🇷 Deep dive into the new Sanofi x Owkin partnership in @Le_Figaro, covering the unique agentic infrastructure Owkin brings with K Pro and how it fits Sanofi’s strategic vision for AI - thank you Marie Bartnik for the detailed reporting. Read here (FR): lefigaro.fr/economie/sanofi-…
1
2
169
Today Owkin announces a multi-year strategic collaboration with @sanofi to co-develop next-generation biopharma agents, to be backed by a five-year license for K Pro, Owkin’s AI Scientist. Read the press release here: owkin.com/newsfeed/owkin-to-…
2
5
379
We're excited to participate in the inaugural Pulmonary Clinical Trials Workshop, where our CEO & Co-founder, @TClozel, will deliver the keynote lecture "Towards New Autopiloted Agentic Breakthroughs in Lung Diseases." Learn more about the workshop 👉 pctmeeting.com/
147
Load more